Project Grant 2334660

Award Date 6/15/24
Completion Date 5/31/27
Dollars Obligated $503K
Federal Grant Program
47.074
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01609, USA
Similar Awards
This Project Grant award of $878,496 from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) supports research to understand the role of STAT5 signaling in placental dysfunction, inflammation, and fetal immune activation. The project aims to investigate how the STAT2 and STAT5B proteins in the JAK/STAT signaling pathway contribute to immune processes that support healthy pregnancies. Through innovative techniques and human placental organoid models, the research...
This National Science Foundation (NSF) Project Grant award under the Engineering program (CFDA 47.041) provides $650,000 to Rowan University to develop lipid nanoparticles (LNPs) as tools to study the role of oxygen levels and inflammation in healthy and pathologic pregnancy. The goal is to use these LNPs to investigate how oxygen and immune-related pathways influence placenta development and function, which can lead to pregnancy-related diseases. This research, spanning July 2025 to June...
This Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), provides $503,000 to Harvey Mudd College to enhance understanding of extracellular vesicle biogenesis through substrate-associated signals. The research will interrogate factors influencing extracellular vesicle formation and selective cargo packaging in astrocytes. Engineered hydrogel substrates engaging integrins expressed by...
The National Science Foundation, through its Integrative Activities program (CFDA 47.083), has awarded a $160,000 project grant to Iowa State University of Science and Technology (Iowa State University) to develop an innovative 3D cell culture platform that can model the transport of pharmaceutical agents across the placental barrier. The project aims to enable quantitative studies on a wide range of pharmaceuticals, understand their interactions, transport through the vasculature, and...
This $500,000 National Science Foundation project grant supports research to advance the biom anufacturing of extracellular vesicles through the integration of human induced pluripotent stem cell technology, genome engineering, and membrane nanofabrication. The primary recipient is Syracuse University, with Rochester Institute of Technology serving as a sub-awardee. Under the Biological Sciences program (CFDA 47.074), the grantees will work to generate a stable human iPSC line with enhanced EV...
The National Institute of Child Health and Human Development (NICHD) awarded a $411,125 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Syracuse University to develop a microfluidic human placenta organoid model. The goal is to generate human trophoblast stem cells (HTSCs) from induced pluripotent stem cells and use them to create a placenta organoid system that can replicate early/mid-gestation placental development. The researchers will study the role of...
This National Science Foundation (NSF) Biological Sciences program project grant, awarded to Oregon Health & Science University (OHSU), aims to uncover the underlying biophysical mechanisms of directed cell migration. The $1,049,497 grant, with a period of performance from January 2024 to December 2027, will examine how actin cytoskeletal networks and adhesion receptors interact as interdependent subsystems to facilitate matrix-guided cell migration, which is crucial for tissue formation and...
This National Science Foundation (NSF) Project Grant under the Biological Sciences program (CFDA 47.074) provides $668,572 in funding to Northeastern University to conduct research on the molecular and biophysical mechanisms underlying contractile valve assembly and function. The research aims to characterize the inner structure and regulatory mechanisms of a donut-shaped contractile valve in the reproductive system of the nematode C. elegans, using advanced microscopy, genetic perturbations,...
This National Science Foundation award under the Biological Sciences program (CFDA 47.074) provides $260,819 to Rollins College from July 2022 through June 2024 to test the role of exosomes in regulating steroidogenesis. Specifically, the grantee will determine if exosomes originating from endocrine cells carry biochemical information to initiate local steroid hormone production in non-endocrine organs of an anolis lizard model. The research aims to establish if local steroidogenesis increases...
This National Science Foundation (NSF) Project Grant under CFDA Number 47.041 - Engineering provides $360,000 in funding to Cornell University from July 1, 2023 to June 30, 2026 to develop a novel biosensing platform for the simultaneous detection and quantification of exosomes (small vesicles released from cells) and their molecular cargo. The key objectives are to: (1) develop methods to capture, quantify, and profile exosomes using a plasmonic biosensor; (2) develop techniques to lyse the...

This National Science Foundation (NSF) Biological Sciences project grant, awarded to Worcester Polytechnic Institute (WPI), aims to better understand the role of trophoblast cells and extracellular vesicles (exosomes) in placental function and development. The $502,999 award, effective June 15, 2024 through May 31, 2027, will focus on two key objectives: 1) characterizing how oxygen levels and biochemical factors influence trophoblast invasion of the extracellular matrix, and 2) examining how these environmental factors alter the composition and function of trophoblast-derived exosomes and their impact on trophoblast invasiveness. The anticipated outcomes may inform molecular mechanisms regulating cellular invasion in both healthy and disease states, while also building research capacity and training at the intersection of cell biology and biomanufacturing. No sub-awards are planned under this grant.

Generated 3/18/25, 4:16 AM